| Literature DB >> 31353262 |
Luiz Osório Leiria1, Chih-Hao Wang1, Matthew D Lynes1, Kunyan Yang1, Farnaz Shamsi1, Mari Sato1, Satoru Sugimoto1, Emily Y Chen2, Valerie Bussberg2, Niven R Narain2, Brian E Sansbury3, Justin Darcy1, Tian Lian Huang1, Sean D Kodani1, Masaji Sakaguchi1, Andréa L Rocha4, Tim J Schulz5, Alexander Bartelt6, Gökhan S Hotamisligil7, Michael F Hirshman1, Klaus van Leyen8, Laurie J Goodyear1, Matthias Blüher9, Aaron M Cypess10, Michael A Kiebish2, Matthew Spite3, Yu-Hua Tseng11.
Abstract
Distinct oxygenases and their oxylipin products have been shown to participate in thermogenesis by mediating physiological adaptations required to sustain body temperature. Since the role of the lipoxygenase (LOX) family in cold adaptation remains elusive, we aimed to investigate whether, and how, LOX activity is required for cold adaptation and to identify LOX-derived lipid mediators that could serve as putative cold mimetics with therapeutic potential to combat diabetes. By utilizing mass-spectrometry-based lipidomics in mice and humans, we demonstrated that cold and β3-adrenergic stimulation could promote the biosynthesis and release of 12-LOX metabolites from brown adipose tissue (BAT). Moreover, 12-LOX ablation in mouse brown adipocytes impaired glucose uptake and metabolism, resulting in blunted adaptation to the cold in vivo. The cold-induced 12-LOX product 12-HEPE was found to be a batokine that improves glucose metabolism by promoting glucose uptake into adipocytes and skeletal muscle through activation of an insulin-like intracellular signaling pathway.Entities:
Keywords: 12-HEPE; adipocytes; brown adipose tissue; diabetes; eicosapentaenoic acid; fat; lipidomic; lipokine; obesity; thermogenesis
Year: 2019 PMID: 31353262 PMCID: PMC6774888 DOI: 10.1016/j.cmet.2019.07.001
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287